NCI-H1417 [H1417]
NCI-H1417 [H1417]
规格:
货期:
编号:TS211348
品牌:Testobio
| 产品名称： | NCI-H1417 H1417 |
|---|---|
| 商品货号： | TS211348 |
| Organism： | Homo sapiens, human |
| Tissue： | lung |
| Product Format： | frozen |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | stage E,carcinoma; classic small cell lung cancer |
| Age： | 61 years |
| Gender： | female |
| Ethnicity： | Caucasian |
| Applications： | The line was established in May 1986. |
| Images： |  |
| Derivation： | The line was established in May 1986. |
| Clinical Data： | The patient was a smoker. female Caucasian 61 years |
| Comments： | The line was established in May 1986. The patient was a smoker. 50 pack years. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Cultures can be maintained by the addition of fresh medium. xa0Alternatively, cultures can be established by standing culture flask vertically until cell clusters settle to bottom of flask. xa0Remove approximately 1/3 of the culture medium. xa0Break up clusters by gently pipetting and add fresh medium. xa0Expand cultures into new culture vessels as necessary.
Add fresh medium every 2 to 4 days (depending on cell density). |
| Cryopreservation： | Culture medium, 95%; DMSO, 5% |
| STR Profile： | Amelogenin: X CSF1PO: 11 D13S317: 8,11 D16S539: 12,13 D5S818: 12 D7S820: 8,10 THO1: 8,9.3 TPOX: 8,11 vWA: 19 |
| Name of Depositor： | AF Gazdar, JD Minna |
| Deposited As： | Homo sapiens |
| Year of Origin： | 1986 |
| References： | NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
NCI-H1417 [H1417]
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | NCI-H1417 H1417 |
|---|---|
| 商品货号： | TS211348 |
| Organism： | Homo sapiens, human |
| Tissue： | lung |
| Product Format： | frozen |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | stage E,carcinoma; classic small cell lung cancer |
| Age： | 61 years |
| Gender： | female |
| Ethnicity： | Caucasian |
| Applications： | The line was established in May 1986. |
| Images： | |
| Derivation： | The line was established in May 1986. |
| Clinical Data： | The patient was a smoker. female Caucasian 61 years |
| Comments： | The line was established in May 1986. The patient was a smoker. 50 pack years. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Cultures can be maintained by the addition of fresh medium. xa0Alternatively, cultures can be established by standing culture flask vertically until cell clusters settle to bottom of flask. xa0Remove approximately 1/3 of the culture medium. xa0Break up clusters by gently pipetting and add fresh medium. xa0Expand cultures into new culture vessels as necessary.
Add fresh medium every 2 to 4 days (depending on cell density). |
| Cryopreservation： | Culture medium, 95%; DMSO, 5% |
| STR Profile： | Amelogenin: X CSF1PO: 11 D13S317: 8,11 D16S539: 12,13 D5S818: 12 D7S820: 8,10 THO1: 8,9.3 TPOX: 8,11 vWA: 19 |
| Name of Depositor： | AF Gazdar, JD Minna |
| Deposited As： | Homo sapiens |
| Year of Origin： | 1986 |
| References： | NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. |
